Clostridium Difficile and COVID-19: General Data, Ribotype, Clinical Form, Treatment-Our Experience from the Largest Infectious Diseases Hospital in Western Romania

Clostridium Difficile and COVID-19: General Data, Ribotype, Clinical Form, Treatment-Our Experience from the Largest Infectious Diseases Hospital in Western Romania

<i>Background and Objectives</i>: In Coronavirus Disease 2019 (COVID-19), which is caused by the infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the clinical manifestations are primarily related to the pulmonary system. Under 10% of cases also develop gastroi...

Full description

Bibliographic Details
Main Authors: Adelina Raluca Marinescu, Ruxandra Laza, Virgil Filaret Musta, Talida Georgiana Cut, Raluca Dumache, Anca Tudor, Mirela Porosnicu, Voichita Elena Lazureanu, Monica Licker
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Medicina
Subjects:
clostridium difficile infection (CDI)
COVID-19 pandemic
risk factors
outcome
ribotype
antibiotic usage
Online Access:https://www.mdpi.com/1648-9144/57/10/1099

Internet

https://www.mdpi.com/1648-9144/57/10/1099

Similar Items